204 related articles for article (PubMed ID: 19187806)
21. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
[TBL] [Abstract][Full Text] [Related]
22. General overview of radioimmunotherapy of solid tumors.
Navarro-Teulon I; Lozza C; Pèlegrin A; Vivès E; Pouget JP
Immunotherapy; 2013 May; 5(5):467-87. PubMed ID: 23638743
[TBL] [Abstract][Full Text] [Related]
23. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
DeNardo GL
Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
[TBL] [Abstract][Full Text] [Related]
24. Radioimmunotherapy for Treatment of Acute Leukemia.
Bodet-Milin C; Kraeber-Bodéré F; Eugène T; Guérard F; Gaschet J; Bailly C; Mougin M; Bourgeois M; Faivre-Chauvet A; Chérel M; Chevallier P
Semin Nucl Med; 2016 Mar; 46(2):135-46. PubMed ID: 26897718
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of radioimmunotherapy of experimental pneumococcal infection.
Dadachova E; Burns T; Bryan RA; Apostolidis C; Brechbiel MW; Nosanchuk JD; Casadevall A; Pirofski L
Antimicrob Agents Chemother; 2004 May; 48(5):1624-9. PubMed ID: 15105113
[TBL] [Abstract][Full Text] [Related]
26. PET imaging facilitates antibody screening for synergistic radioimmunotherapy with a
Ren J; Xu M; Chen J; Ding J; Wang P; Huo L; Li F; Liu Z
Theranostics; 2021; 11(1):304-315. PubMed ID: 33391476
[No Abstract] [Full Text] [Related]
27. Cancer radioimmunotherapy with alpha-emitting nuclides.
Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
[TBL] [Abstract][Full Text] [Related]
28. Monoclonal antibody based radiopharmaceuticals for imaging and therapy.
Lin M; Paolillo V; Le DB; Macapinlac H; Ravizzini GC
Curr Probl Cancer; 2021 Oct; 45(5):100796. PubMed ID: 34657748
[TBL] [Abstract][Full Text] [Related]
29. The new golden era for radioimmunotherapy: not just for lymphomas anymore.
Tomblyn MB; Katin MJ; Wallner PE
Cancer Control; 2013 Jan; 20(1):60-71. PubMed ID: 23302908
[TBL] [Abstract][Full Text] [Related]
30. Radioimmunoconjugates for the treatment of cancer.
Kraeber-Bodéré F; Bodet-Milin C; Rousseau C; Eugène T; Pallardy A; Frampas E; Carlier T; Ferrer L; Gaschet J; Davodeau F; Gestin JF; Faivre-Chauvet A; Barbet J; Chérel M
Semin Oncol; 2014 Oct; 41(5):613-22. PubMed ID: 25440606
[TBL] [Abstract][Full Text] [Related]
31. Combination Radioimmunotherapy Strategies for Solid Tumors.
Zaheer J; Kim H; Lee YJ; Kim JS; Lim SM
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717302
[TBL] [Abstract][Full Text] [Related]
32. Imaging, dosimetry, and radioimmunotherapy with iodine 131-labeled anti-CD37 antibody in B-cell lymphoma.
Kaminski MS; Fig LM; Zasadny KR; Koral KF; DelRosario RB; Francis IR; Hanson CA; Normolle DP; Mudgett E; Liu CP
J Clin Oncol; 1992 Nov; 10(11):1696-711. PubMed ID: 1403053
[TBL] [Abstract][Full Text] [Related]
33. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry.
Langmuir VK; Fowler JF; Knox SJ; Wessels BW; Sutherland RM; Wong JY
Med Phys; 1993; 20(2 Pt 2):601-10. PubMed ID: 8492769
[TBL] [Abstract][Full Text] [Related]
34. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
[TBL] [Abstract][Full Text] [Related]
35. Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice.
Juweid ME
J Nucl Med; 2002 Nov; 43(11):1507-29. PubMed ID: 12411555
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
Kelly MP; Lee ST; Lee FT; Smyth FE; Davis ID; Brechbiel MW; Scott AM
Prostate; 2009 Jan; 69(1):92-104. PubMed ID: 18942092
[TBL] [Abstract][Full Text] [Related]
37. Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases.
Dadachova E; Casadevall A
Curr Opin Investig Drugs; 2008 Feb; 9(2):184-8. PubMed ID: 18246521
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells.
Bryan RA; Jiang Z; Morgenstern A; Bruchertseifer F; Casadevall A; Dadachova E
Future Microbiol; 2013 Sep; 8(9):1081-9. PubMed ID: 24020737
[TBL] [Abstract][Full Text] [Related]
39. Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation.
Bethge WA; Wilbur DS; Sandmaier BM
Leuk Lymphoma; 2006 Jul; 47(7):1205-14. PubMed ID: 16923548
[TBL] [Abstract][Full Text] [Related]
40. Radioimmunotherapy of Blastomycosis in a Mouse Model With a (1→3)-β-Glucans Targeting Antibody.
Helal M; Allen KJH; van Dijk B; Nosanchuk JD; Snead E; Dadachova E
Front Microbiol; 2020; 11():147. PubMed ID: 32117166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
